|
[Related PubMed/MEDLINE] Total Number of Papers: 662
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: IL-15 |
Long Form |
: interleukin-15 |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Altered expression of MiR-186-5p and its target genes after spinal cord ischemia-reperfusion injury in rats. |
GO, I/R, miRs, TNF-alpha |
2 |
2020 |
Amelioration of Cisplatin-Induced Ototoxicity in Rats by L-arginine: The Role of Nitric Oxide, Transforming Growth Factor Beta 1 and Nrf2/HO-1 Pathway. |
ABR, HO-1, TGF-beta1, TNF-alpha |
3 |
2020 |
Blockade of Discoidin Domain Receptor 2 as a Strategy for Reducing Inflammation and Joint Destruction in Rheumatoid Arthritis Via Altered Interleukin-15 and Dkk-1 Signaling in Fibroblast-Like Synoviocytes. |
CAIA, DDR2, FLS, miR-103a, mRNA, RA |
4 |
2020 |
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. |
AD, NK |
5 |
2020 |
Combination of CD8beta Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques. |
ART, HIV, RMs |
6 |
2020 |
Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study. |
CR, mAb, MCC, PD-L1 |
7 |
2020 |
CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy. |
BiTE, CARs, CRISPR, FDA, USA, GFP, HDR, IL-13, TRAC |
8 |
2020 |
Effects of Regular Taekwondo Intervention on Oxidative Stress Biomarkers and Myokines in Overweight and Obese Adolescents. |
BDNF, BMI, MDA, SOD |
9 |
2020 |
Effects of short-term physical training on the interleukin-15 signalling pathway and glucose tolerance in aged rats. |
--- |
10 |
2020 |
Electrotransfer of IL-15/IL-15Ralpha Complex for the Treatment of Established Melanoma. |
GET, pDNA |
11 |
2020 |
Exercise-Induced Myokines can Explain the Importance of Physical Activity in the Elderly: An Overview. |
BAIBA, BMP-7, IGF-1, SDF-1, SPARC, VEGF-A |
12 |
2020 |
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10. |
cDC1, hetIL-15, IFN-gamma, IHC, NK |
13 |
2020 |
Highly oxidized low-density lipoprotein mediates activation of monocytes but does not confer interleukin-1beta secretion nor interleukin-15 transpresentation function. |
LDL, LPS |
14 |
2020 |
IL-15 and IL15RA in Osteoarthritis: Association With Symptoms and Protease Production, but Not Structural Severity. |
IL15RA, MMP-1 and -3, NP, OA |
15 |
2020 |
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment. |
NK, NSCLC, RLI |
16 |
2020 |
Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells. |
CARs, iRC9, NK |
17 |
2020 |
Innate Cytokine Induced Early Release of IFNgamma and CC Chemokines from Hypoxic Human NK Cells Is Independent of Glucose. |
IFN, NK |
18 |
2020 |
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status. |
CTC, DFS, OS |
19 |
2020 |
Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink. |
--- |
20 |
2020 |
Interleukin 15 upregulates the expression of PD-1 and TIM-3 on CD4+ and CD8+ T cells. |
HBV, PBMCs, PD-1, Tim-3 |
21 |
2020 |
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors. |
ICD, mAb, NIR-PIT, NK |
22 |
2020 |
Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development. |
RA, RF, UA |
23 |
2020 |
Interleukin-15 in autoimmunity. |
--- |
24 |
2020 |
Intestinal epithelial cell-derived IL-15 determines local maintenance and maturation of intra-epithelial lymphocytes in the intestine. |
BECs, IECs, IELs, IL-15cKO, Vil-Cre |
25 |
2020 |
Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT-11-Induced Diarrhea in Mice. |
beta-GD, ELISA, IL-1, IL-6, IL-7, JWXLD, TCM, TNF-alpha, TNF-beta, UGT1A1 |
26 |
2020 |
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes InVivo Persistence and Enhances Anti-tumor Activity. |
CIS, iPSC-NK cell, mTOR, NK |
27 |
2020 |
Nano Chromium Picolinate Improves Gene Expression Associated with Insulin Signaling in Porcine Skeletal Muscle and Adipose Tissue. |
nCrPic, PI3K, PPARgamma, SOCS3, TNF-alpha, UCP3 |
28 |
2020 |
Poor Oral Hygiene and High Levels of Inflammatory Cytokines in Saliva Predict the Risk of Overweight and Obesity. |
--- |
29 |
2020 |
Serum interleukin 15 in anorexia nervosa: Comparison to normal weight and obese girls. |
AN, CRP |
30 |
2020 |
Serum Level and Gene Expression of Interleukin-15 Do Not Correlate with Villous Atrophy in Celiac Disease Patients. |
CD, qPCR |
31 |
2020 |
Short-Term Resistance Training Supported by Whole-Body Cryostimulation Induced a Decrease in Myostatin Concentration and an Increase in Isokinetic Muscle Strength. |
IL-6 |
32 |
2020 |
Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model. |
CTLA-4, cyto-IL-15, NK, PD-L1 |
33 |
2020 |
The advent of de novo proteins for cancer immunotherapy. |
IL-2 |
34 |
2020 |
The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor. |
NK, NK-92 |
35 |
2020 |
The construction of a new oncolytic herpes simplex virus expressing murine interleukin-15 with gene-editing technology. |
mIL-15 |
36 |
2020 |
The IL-15 / sIL-15Ralpha complex modulates immunity without effect on asthma features in mouse. |
IL-15Cx, NK |
37 |
2020 |
Trans-endocytosis of intact IL-15Ralpha-IL-15 complex from presenting cells into NK cells favors signaling for proliferation. |
NK |
38 |
2019 |
Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium. |
IDO, UPA, VEGFR2 |
39 |
2019 |
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck. |
EGFR, IL15Ralpha, NK, SCCHN |
40 |
2019 |
Anti-Inflammatory Effect of Surfactant Lipid in the Vaginal Mucosa: A Pilot Study. |
IL-1RA |
41 |
2019 |
Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials. |
CAR, IL-2 |
42 |
2019 |
Development of a recombinant human IL-15sIL-15Ralpha/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model. |
PD-1 |
43 |
2019 |
Expression of bovine interleukin 15 in Pichia pastoris and study on its biological activity: a T-cell activator. |
CPT1a |
44 |
2019 |
IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective gamma-chain cytokines, decreases leukemic T-cell viability. |
ATL, T-LGLL |
45 |
2019 |
Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus. |
--- |
46 |
2019 |
Interleukin-15 Signaling in HIF-1alpha Regulation in Natural Killer Cells, Insights Through Mathematical Models. |
HIF-1alpha, mTOR, NF-kappaB, NK, STAT3 |
47 |
2019 |
Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development. |
AD, eGDR, HOMA-IR, IL-6, LADA, T1D |
48 |
2019 |
Mechanistic and Structural Insights on the IL-15 System through Molecular Dynamics Simulations. |
--- |
49 |
2019 |
MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. |
ILCs, MCMV, miR-142, NK, SOCS1, TGF-beta |
50 |
2019 |
Novel Associations Between Interleukin-15 Polymorphisms and Post-training Changes of Body Composition Parameters in Young Nonobese Women. |
FFM |
51 |
2019 |
Overexpression of Interleukin-15 exhibits improved glucose tolerance and promotes GLUT4 translocation via AMP-Activated protein kinase pathway in skeletal muscle. |
AMPK, AS160, GLUT4, IL-15TG, TBC1D1 |
52 |
2019 |
Plasticity of antimicrobial and phagocytic programs in human macrophages. |
IFN-gamma, TLR1 |
53 |
2019 |
Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. |
BSFS, GSRS, VHCD |
54 |
2019 |
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. |
BSFS, GSRS |
55 |
2019 |
Serum Interleukin-15 is a Marker of Alopecia Areata Severity. |
AA, SALT score |
56 |
2019 |
The exercise cytokine interleukin-15 rescues slow wound healing in aged mice. |
STAT3 |
57 |
2019 |
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells. |
NK |
58 |
2019 |
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity. |
NK, TGF-beta |
59 |
2019 |
Treatment with Recombinant Interleukin-15 (IL-15) Increases the Number of T Cells and Natural Killer (NK) Cells and Levels of Interferon-gamma (IFN-gamma) in a Rat Model of Sepsis. |
IFN-gamma, NK |
60 |
2019 |
Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells. |
ADCC, IMC |
61 |
2018 |
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS. |
BiKEs, MDS, MDSCs, NK, TIGIT, TriKE |
62 |
2018 |
A genetic variant in IL-15Ralpha correlates with physical activity among European-American adults. |
BMI |
63 |
2018 |
A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities. |
--- |
64 |
2018 |
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment. |
ART, HIV, SIV |
65 |
2018 |
Antibiotics with Interleukin-15 Inhibition Reduce Joint Inflammation and Bone Erosions but Not Cartilage Destruction in Staphylococcus aureus-Induced Arthritis. |
aIL-15ab, TSST-1 |
66 |
2018 |
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. |
IFN-gamma |
67 |
2018 |
Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease. |
GSE |
68 |
2018 |
Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice. |
NB, TH |
69 |
2018 |
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. |
CARs, CB, GVHD, iC9, NK |
70 |
2018 |
Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. |
BRD4, CTCL, miRNA, miRs |
71 |
2018 |
Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy. |
NK, Treg |
72 |
2018 |
Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue. |
--- |
73 |
2018 |
Endometrial Stromal and Epithelial Cells Exhibit Unique Aberrant Molecular Defects in Patients With Endometriosis. |
BMP2, HAND2, MMP7, POSTN, TGF-beta1, ZEB1 |
74 |
2018 |
Exercise-induced myokines: a brief review of controversial issues of this decade. |
BDNF, SPARC |
75 |
2018 |
Expression levels of IL-15 and IL-17 in synovial fluid of rheumatoid arthritis animal model. |
AI, CIA, ELISA, IL-17, RA |
76 |
2018 |
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. |
allo-HCT, NK |
77 |
2018 |
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria. |
amCTLs, CTLs, NK, TCR |
78 |
2018 |
IL-15/IL-15Ralpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. |
AML |
79 |
2018 |
Interleukin 15 concentrations in follicular fluid and their effect on oocyte maturation in subfertile women undergoing intracytoplasmic sperm injection. |
BMI, FF, ICSI |
80 |
2018 |
Interleukin-15 derived from Guanylin-GC-C-expressing macrophages inhibits fatty acid synthase in adipocytes. |
DTG, GCC, Gn, HFD |
81 |
2018 |
Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors. |
FAPs |
82 |
2018 |
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo. |
ADCC, HIV, IFN-gamma, NK |
83 |
2018 |
Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells. |
IL-2, MHC, MP |
84 |
2018 |
Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques. |
IL-15Ralpha |
85 |
2018 |
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. |
CAR, NHL, PSI |
86 |
2018 |
Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and gammadelta T Cell Responses and Confers Heterologous Protection. |
dpv, GPI, MLVs, PRRS, PRRSV, PRRSV |
87 |
2018 |
Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity. |
CS, MG |
88 |
2018 |
Serum Interleukin-15 and its relationship with adiposity Indices before and after short-term endurance exercise. |
--- |
89 |
2018 |
The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. |
SIV |
90 |
2018 |
The relationship between plasma interleukin-15 levels and sarcopenia in outpatient older people. |
--- |
91 |
2018 |
The systemic myokine response of decorin, interleukin-6 (IL-6) and interleukin-15 (IL-15) to an acute bout of blood flow restricted exercise. |
BFR-RE, IL-6 |
92 |
2017 |
A novel self-cleavable tag Zbasic-∆I-CM and its application in the soluble expression of recombinant human interleukin-15 in Escherichia coli. |
E. coli |
93 |
2017 |
Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. |
GFAP, NK |
94 |
2017 |
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression. |
--- |
95 |
2017 |
Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease. |
Ago2, IFN-gamma, qPCR, RISC, siRNA, TG2, TNF-alpha |
96 |
2017 |
Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells. |
DKI, NK |
97 |
2017 |
Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis. |
--- |
98 |
2017 |
Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses. |
DCs, FV, NK |
99 |
2017 |
Effects of three IL-15 variants on NCI-H446 cell proliferation and expression of cell cycle regulatory molecules. |
--- |
100 |
2017 |
Environmental stimuli shape microglial plasticity in glioma. |
BDNF, EE, NK |
|